Trials360 Developed Stroke Rat Model
Description:
Greetings from the Trials 360 monthly newsletter!
We are thrilled to announce another milestone at Trials 360:
The successful development of a Stroke Rat Model through Common Carotid Artery Occlusion (CCAO).
This achievement holds significant importance in medical research, particularly in the study of Ischemic Stroke, a major global health concern. Having a reliable animal model for Ischemic Stroke will greatly enhance our understanding of its mechanisms and potential therapeutic interventions.
Trials 360 leads in preclinical and clinical trials, showcasing expertise in innovative stroke rat models through CCAO. Our comprehensive services extend beyond stroke, offering tailored solutions for a spectrum of disease models (such as vascular dementia, cognitive impairment, or other neurological deficits that may result from stroke or be related to the underlying mechanisms of stroke) to advance your research.
We are also excited to share that Trials 360 has previously developed a respiratory inflammation model, demonstrating our expertise in this area as well. With proof-of-concept studies in both inflammatory and stroke models, we are well-equipped to provide comprehensive services in these domains.
This milestone further solidifies our commitment to advancing medical research and providing innovative solutions for a wide range of conditions